← Back to Search

Study trial for Pulmonary Hemorrhage (BloodyBlocker Trial)

N/A
Waitlist Available
Led By F Robert Purdy, FRCA
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 10 minutes from successful intubation
Awards & highlights

BloodyBlocker Trial Summary

This trial will compare a new bronchial blocker device against 3 existing methods of lung isolation in an emergency scenario.

Eligible Conditions
  • Pulmonary Hemorrhage

BloodyBlocker Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 10 minutes from start of direct laryngoscopy
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 10 minutes from start of direct laryngoscopy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Total time to successful lung isolation.
Secondary outcome measures
Model utility
Time to successful intubation
Time to successful method placement

BloodyBlocker Trial Design

1Treatment groups
Experimental Treatment
Group I: Study trialExperimental Treatment1 Intervention
All participants will perform pulmonary blockade on an intubating manikin using 4 different methods: Endobronchial intubation with an endotracheal tube; Bronchial blocker attached to the outside of an endotracheal tube; Double lumen endotracheal tube; and Intraluminal placement of bronchial blocker.

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,415 Previous Clinical Trials
2,466,996 Total Patients Enrolled
F Robert Purdy, FRCAPrincipal InvestigatorThe University of British Columbia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Novel Method of Lung Isolation Compared With Standard Methods in a Model of Massive Pulmonary Hemorrhage
F. Robert Purdy 2021. "A Novel Method of Lung Isolation Compared With Standard Methods in a Model of Massive Pulmonary Hemorrhage". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05001607.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top